Drug metabolism assessed as human recombinant FMO5-mediated compound formation from 50 uM E7016 in presence of dog liver cytosolic fractions after 60 ...

Basic Information

ID: ALA3531521

Type: ADME

Description: Drug metabolism assessed as human recombinant FMO5-mediated compound formation from 50 uM E7016 in presence of dog liver cytosolic fractions after 60 mins by LC-MS/MS method

Format: BAO_0000221

Organism: Homo sapiens

Tissue: Liver

Target:  Dimethylaniline monooxygenase [N-oxide-forming] 5(ALA3430871)

Document:  ALA3525952

Drug metabolism assessed as human recombinant FMO5-mediated compound formation from 50 uM E7016 in presence of dog liver cytosolic fractions after 60 mins by LC-MS/MS method: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
381.391.961.96